Zimmer receives clearance for pediatric use of Universal Clamp Spinal Fixation System

Zimmer Holdings, Inc. (NYSE: ZMH; SIX: ZMH) announced today that it has received an additional clearance for its proprietary Universal Clamp Spinal Fixation System.  A first for the United States, the system is now indicated for treatment of idiopathic and neuromuscular scoliosis in patients eight years of age or older.  The Universal Clamp Spinal Fixation System is used in conjunction with spinal fusion surgeries.

Scoliosis is a debilitating condition characterized by spine curvature and back pain. In the United States, scoliosis affects approximately two to three percent of the population with more than 27,000 cases a year determined to be serious enough to require surgery.  Scoliosis is commonly diagnosed in childhood and early adolescence, with between three and five of every 1,000 children developing spinal curves that are considered large enough for treatment.  The most common surgical intervention performed to correct severe scoliosis is spinal fusion.  

Zimmer's Universal Clamp System was designed for use in conjunction with spinal deformity procedures.  Introduced in Europe in 2006 and in the United States in 2008, the Universal Clamp Implant offers a pedicle-sparing approach for malformed or small thoracic pedicles while still providing similar stability to pedicle screw constructs. The Universal Clamp band spreads contact forces over a greater surface area, thereby reducing the risk of pulling through the lamina compared to wires and hooks.  The system's reduction instrumentation allows surgeons to sequentially reduce deformity and spread the reduction forces over multiple levels.

"Scoliosis affects a significant number of young patients in the United States each year," said Steve Healy, President of Zimmer Spine.  "We are excited to make the Universal Clamp System available as an advanced solution for surgeons treating young patients."

Since its introduction, the Universal Clamp System has been successfully used in more than 24,000 procedures worldwide.  Following the latest clearance, Zimmer can now provide training and education for surgeons to treat child and adolescent patients in the United States with the technology.

SOURCE Zimmer Holdings, Inc.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New treatment offers hope for children with Acute Flaccid Myelitis